{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T10:17:04Z","timestamp":1706091424613},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,4,15]],"date-time":"2004-04-15T00:00:00Z","timestamp":1081987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,4,15]],"date-time":"2004-04-15T00:00:00Z","timestamp":1081987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2004,6,1]]},"DOI":"10.1038\/sj.leu.2403370","type":"journal-article","created":{"date-parts":[[2004,4,15]],"date-time":"2004-04-15T11:09:54Z","timestamp":1082027394000},"page":"1127-1137","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Constitutively activated phosphatidylinositol 3-kinase primes platelets from patients with chronic myelogenous leukemia for thrombopoietin-induced aggregation"],"prefix":"10.1038","volume":"18","author":[{"given":"Y","family":"Kubota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Kitanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Okutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Taminato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,4,15]]},"reference":[{"key":"BF2403370_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/369533a0","volume":"369","author":"FJ de Sauvage","year":"1994","unstructured":"de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA et al. Stimulation of megakaryocytopoieis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533\u2013538.","journal-title":"Nature"},{"key":"BF2403370_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/369565a0","volume":"369","author":"S Lok","year":"1994","unstructured":"Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994; 369: 565\u2013568.","journal-title":"Nature"},{"key":"BF2403370_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/369571a0","volume":"369","author":"F Wendling","year":"1994","unstructured":"Wendling F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M et al. c-Mpl ligand is a humoral regulator of megakaryopoiesis. Nature 1994; 369: 571\u2013574.","journal-title":"Nature"},{"key":"BF2403370_CR4","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/0092-8674(94)90450-2","volume":"77","author":"TD Bartley","year":"1994","unstructured":"Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117\u20131124.","journal-title":"Cell"},{"key":"BF2403370_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0014-5793(94)01008-0","volume":"353","author":"Y Sohma","year":"1995","unstructured":"Sohma Y, Akahori H, Seki N, Hori T, Ogami K, Kato T et al. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett 1995; 353: 57\u201361.","journal-title":"FEBS Lett"},{"key":"BF2403370_CR6","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1182\/blood.V82.5.1395.1395","volume":"82","author":"N Mathia","year":"1993","unstructured":"Mathia N, Louache F, Vainchenker W, Wendling F . Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 1993; 82: 1395\u20131401.","journal-title":"Blood"},{"key":"BF2403370_CR7","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1055\/s-0038-1649979","volume":"74","author":"H Kojima","year":"1995","unstructured":"Kojima H, Hamazaki Y, Nagata Y, Todokoro K, Nagasawa T, Abe T . Modulation of platelet activation in vitro by thrombopoietin. Thromb Haemost 1995; 74: 1541\u20131545.","journal-title":"Thromb Haemost"},{"key":"BF2403370_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/stem.140439","volume":"14","author":"Y Kubota","year":"1996","unstructured":"Kubota Y, Arai T, Tanaka T, Yamaoka G, Kiuchi H, Kajikawa T et al. Thrombopoietin modulates platelet activation in vitro through protein-tyrosine phosphorylation. Stem Cells 1996; 14: 439\u2013444.","journal-title":"Stem Cells"},{"key":"BF2403370_CR9","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood.V87.7.2762.bloodjournal8772762","volume":"87","author":"G Montrucchio","year":"1996","unstructured":"Montrucchio G, Brizzi MF, Calosso G, Marengo S, Pegoraro L, Camussi G . Effects of recombinant human megakaryocyte growth and development factor on platelet activation. Blood 1996; 87: 2762\u20132768.","journal-title":"Blood"},{"key":"BF2403370_CR10","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1182\/blood.V87.11.4664.bloodjournal87114664","volume":"87","author":"A Oda","year":"1996","unstructured":"Oda A, Miyakawa Y, Druker BJ, Ozaki K, Yabusaki K, Shirasawa Y et al. Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood 1996; 87: 4664\u20134670.","journal-title":"Blood"},{"key":"BF2403370_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/sj.leu.2401248","volume":"13","author":"WK Hofmann","year":"1999","unstructured":"Hofmann WK, Ottmann OG, Hoelzer D . Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies? Leukemia 1999; 13: 14\u201318.","journal-title":"Leukemia"},{"key":"BF2403370_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/sj.leu.2401620","volume":"14","author":"K Kaushansky","year":"2000","unstructured":"Kaushansky K . Use of thrombopoietic growth factors in acute leukemia. Leukemia 2000; 14: 505\u2013508.","journal-title":"Leukemia"},{"key":"BF2403370_CR13","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1182\/blood.V100.10.3457","volume":"100","author":"DJ Kuter","year":"2002","unstructured":"Kuter DJ, Begley CG . Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood 2002; 100: 3457\u20133469.","journal-title":"Blood"},{"key":"BF2403370_CR14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1055\/s-2007-996114","volume":"23","author":"A Wehmeier","year":"1997","unstructured":"Wehmeier A, Sudhoff T, Meierkord F . Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders. Semin Thromb Hemost 1997; 23: 391\u2013402.","journal-title":"Semin Thromb Hemost"},{"key":"BF2403370_CR15","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1182\/blood.V88.11.4304.4304","volume":"88","author":"A Oda","year":"1996","unstructured":"Oda A, Miyakawa Y, Druker BJ, Ishida A, Ozaki K, Ohashi H et al. Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin. Blood 1996; 88: 4304\u20134313.","journal-title":"Blood"},{"key":"BF2403370_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1056\/NEJM199802263380903","volume":"338","author":"AR Moliterno","year":"1998","unstructured":"Moliterno AR, Hankins WD, Spivak JL . Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med 1998; 338: 572\u2013580.","journal-title":"N Engl J Med"},{"key":"BF2403370_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1046\/j.1365-2141.2000.01794.x","volume":"108","author":"K Le Blanc","year":"2000","unstructured":"Le Blanc K, Andersson P, Samuelsson J . Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythaemia vera. Br J Haematol 2000; 108: 80\u201385.","journal-title":"Br J Haematol"},{"key":"BF2403370_CR18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1182\/blood.V96.2.771","volume":"96","author":"A Tefferi","year":"2000","unstructured":"Tefferi A, Yoon SY, Li CY . Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis. Blood 2000; 96: 771\u2013772.","journal-title":"Blood"},{"key":"BF2403370_CR19","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/blood.V90.10.4031","volume":"90","author":"Y Horikawa","year":"1997","unstructured":"Horikawa Y, Matsumura I, Hashimoto K, Shiraga M, Kosugi S, Tadokoro S et al. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood 1997; 90: 4031\u20134038.","journal-title":"Blood"},{"key":"BF2403370_CR20","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/sj.leu.2400845","volume":"11","author":"JJ Kiladjian","year":"1997","unstructured":"Kiladjian JJ, Elkassar N, Hetet G, Briere J, Grandchamp B, Gardin C . Study of the thrombopoietin receptor in essential thrombocythemia. Leukemia 1997; 11: 1821\u20131826.","journal-title":"Leukemia"},{"key":"BF2403370_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/0014-5793(95)01072-M","volume":"374","author":"Y Ezumi","year":"1995","unstructured":"Ezumi Y, Takayama H, Okuma M . Thrombopoietin, a c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro. FEBS Lett 1995; 374: 48\u201352.","journal-title":"FEBS Lett"},{"key":"BF2403370_CR22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood.V86.1.23.bloodjournal86123","volume":"86","author":"Y Miyakawa","year":"1995","unstructured":"Miyakawa Y, Oda A, Druker BJ, Kato T, Miyazaki H, Handa M et al. Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets. Blood 1995; 86: 23\u201327.","journal-title":"Blood"},{"key":"BF2403370_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1042\/bj3160093","volume":"316","author":"B Rodriguez-Linares","year":"1996","unstructured":"Rodriguez-Linares B, Watson SP . Thrombopoietin potentiates activation of human platelets in association with JAK2 and TYK2 phosphorylation. Biochem J 1996; 316: 93\u201398.","journal-title":"Biochem J"},{"key":"BF2403370_CR24","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1046\/j.1365-2141.1997.802720.x","volume":"97","author":"K Usuki","year":"1997","unstructured":"Usuki K, Iki S, Endo M, Izutsu K, Inoue K, Nishimura T et al. Influence of thrombopoietin on platelet activation in myeloproliferative disorders. Br J Haematol 1997; 97: 530\u2013537.","journal-title":"Br J Haematol"},{"key":"BF2403370_CR25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/sj.leu.2402824","volume":"17","author":"F Chang","year":"2003","unstructured":"Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL et al. Involvement of PI3K\/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 2003; 17: 590\u2013603.","journal-title":"Leukemia"},{"key":"BF2403370_CR26","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/sj.leu.2402460","volume":"16","author":"JT Lee Jr","year":"2002","unstructured":"Lee Jr JT, McCubrey JA . The Raf\/MEK\/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 2002; 16: 486\u2013507.","journal-title":"Leukemia"},{"key":"BF2403370_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.leu.2402725","volume":"17","author":"JM Luo","year":"2003","unstructured":"Luo JM, Yoshida H, Komura S, Ohishi N, Pan L, Shigeno K et al. Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia. Leukemia 2003; 17: 1\u20138.","journal-title":"Leukemia"},{"key":"BF2403370_CR28","first-page":"M21","volume":"1470","author":"F Vazquez","year":"2000","unstructured":"Vazquez F, Sellers WR . The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochim Biophys Acta 2000; 1470: M21\u2013M35.","journal-title":"Biochim Biophys Acta"},{"key":"BF2403370_CR29","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1182\/blood.V88.12.4401.bloodjournal88124401","volume":"88","author":"SE Rittenhouse","year":"1996","unstructured":"Rittenhouse SE . Phosphoinositide 3-kinase activation and platelet function. Blood 1996; 88: 4401\u20134414.","journal-title":"Blood"},{"key":"BF2403370_CR30","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1182\/blood.V86.11.4054.bloodjournal86114054","volume":"86","author":"J Chen","year":"1995","unstructured":"Chen J, Herceg-Harjacek L, Groopman JE, Grabarek J . Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. Blood 1995; 86: 4054\u20134062.","journal-title":"Blood"},{"key":"BF2403370_CR31","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1182\/blood.V95.11.3429","volume":"95","author":"JM Pasquet","year":"2000","unstructured":"Pasquet JM, Gross BS, Gratacap MP, Quek L, Pasquet S, Payrastre B et al. Thrombopoietin potentiates collagen receptor signaling in platelets through a phosphatidylinositol 3-kinase-dependent pathway. Blood 2000; 95: 3429\u20133434.","journal-title":"Blood"},{"key":"BF2403370_CR32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1182\/blood.V89.3.883","volume":"89","author":"G Zauli","year":"1997","unstructured":"Zauli G, Bassini A, Vitale M, Gibellini D, Celeghini C, Caramelli E et al. Thrombopoietin enhances the alpha IIb beta 3-dependent adhesion of megakaryocytic cells to fibrinogen or fibronectin through PI 3 kinase. Blood 1997; 89: 883\u2013895.","journal-title":"Blood"},{"key":"BF2403370_CR33","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/379645a0","volume":"379","author":"N Meydan","year":"1996","unstructured":"Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 1996; 379: 645\u2013648.","journal-title":"Nature"},{"key":"BF2403370_CR34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996; 2: 561\u2013566.","journal-title":"Nat Med"},{"key":"BF2403370_CR35","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1126\/science.289.5486.1938","volume":"289","author":"T Schindler","year":"2000","unstructured":"Schindler T, Bornmann W, Pellicena P, Miller WT, Clarkson B, Kuriyan J . Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science 2000; 289: 1938\u20131942.","journal-title":"Science"},{"key":"BF2403370_CR36","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/sj.leu.2402555","volume":"16","author":"P La Rosee","year":"2002","unstructured":"La Rosee P, O'Dwyer ME, Druker BJ . Insights from pre-clinical studies for new combination treatment regimens with the Bcr-Abl kinase inhibitor imatinib mesylate (Gleevec\/Glivec) in chronic myelogenous leukemia: a translational perspective. Leukemia 2002; 16: 1213\u20131219.","journal-title":"Leukemia"},{"key":"BF2403370_CR37","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1006\/abio.1994.1180","volume":"218","author":"Y Ozaki","year":"1994","unstructured":"Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, Kume S . Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 1994; 218: 284\u2013294.","journal-title":"Anal Biochem"},{"key":"BF2403370_CR38","doi-asserted-by":"publisher","first-page":"5666","DOI":"10.1093\/emboj\/20.20.5666","volume":"20","author":"Y Kubota","year":"2001","unstructured":"Kubota Y, Tanaka T, Kitanaka A, Ohnishi H, Okutani Y, Waki M et al. Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase. EMBO J 2001; 20: 5666\u20135677.","journal-title":"EMBO J"},{"key":"BF2403370_CR39","first-page":"720","volume":"10","author":"Y Kubota","year":"1996","unstructured":"Kubota Y, Tanaka T, Yamaoka G, Yamaguchi M, Ohnishi H, Kawanishi K et al. Wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase, inhibits erythropoietin-induced erythroid differentiation of K562 cells. Leukemia 1996; 10: 720\u2013726.","journal-title":"Leukemia"},{"key":"BF2403370_CR40","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1093\/emboj\/16.20.6151","volume":"16","author":"T Skorski","year":"1997","unstructured":"Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK et al. Transformation of hematopoietic cells by BCR\/ABL requires activation of a PI-3k\/Akt-dependent pathway. EMBO J 1997; 16: 6151\u20136161.","journal-title":"EMBO J"},{"key":"BF2403370_CR41","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1046\/j.1365-2141.2001.02624.x","volume":"112","author":"D Best","year":"2001","unstructured":"Best D, Pasquet S, Littlewood TJ, Brunskill SJ, Pallister CJ, Watson SP . Platelet activation via the collagen receptor GPVI is not altered in platelets from chronic myeloid leukaemia patients despite the presence of the constitutively phosphorylated adapter protein CrkL. Br J Haematol 2001; 112: 609\u2013615.","journal-title":"Br J Haematol"},{"key":"BF2403370_CR42","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1046\/j.1365-2141.1998.01115.x","volume":"103","author":"GJ ten Bosch","year":"1998","unstructured":"ten Bosch GJ, Kessler JH, Blom J, Joosten AM, Gambacorti-Passerini C, Melief CJ et al. BCR-ABL oncoprotein is expressed by platelets from CML patients and associated with a special pattern of CrkL phosphorylation. Br J Haematol 1998; 103: 1109\u20131115.","journal-title":"Br J Haematol"},{"key":"BF2403370_CR43","doi-asserted-by":"crossref","first-page":"13874","DOI":"10.1016\/S0021-9258(17)36728-5","volume":"269","author":"FS Vassbotn","year":"1994","unstructured":"Vassbotn FS, Havnen OK, Heldin CH, Holmsen H . Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor alpha-receptor. J Biol Chem 1994; 269: 13874\u201313879.","journal-title":"J Biol Chem"},{"key":"BF2403370_CR44","doi-asserted-by":"crossref","first-page":"21718","DOI":"10.1016\/S0021-9258(17)31864-1","volume":"269","author":"J Grabarek","year":"1994","unstructured":"Grabarek J, Groopman JE, Lyles YR, Jiang S, Bennett L, Zsebo K et al. Human kit ligand (stem cell factor) modulates platelet activation in vitro. J Biol Chem 1994; 269: 21718\u201321724.","journal-title":"J Biol Chem"},{"key":"BF2403370_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/sj.leu.2402341","volume":"16","author":"K Inokuchi","year":"2002","unstructured":"Inokuchi K, Yamaguchi H, Tarusawa M, Futaki M, Hanawa H, Tanosaki S et al. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia \u2013 potential clinical significance. Leukemia 2002; 16: 170\u2013177.","journal-title":"Leukemia"},{"key":"BF2403370_CR46","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1365-2141.1995.tb05364.x","volume":"91","author":"Y Nakata","year":"1995","unstructured":"Nakata Y, Kimura A, Katoh O, Kawaishi K, Hyodo H, Abe K et al. c-kit point mutation of extracellular domain in patients with myeloproliferative disorders. Br J Haematol 1995; 91: 661\u2013663.","journal-title":"Br J Haematol"},{"key":"BF2403370_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1046\/j.1365-2141.1996.6102053.x","volume":"94","author":"M Hallek","year":"1996","unstructured":"Hallek M, Danhauser-Riedl S, Herbst R, Warmuth M, Winkler A, Kolb HJ et al. Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr\/abl kinase in myeloid cells. Br J Haematol 1996; 94: 5\u201316.","journal-title":"Br J Haematol"},{"key":"BF2403370_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.leu.2403241","volume":"18","author":"LS Steelman","year":"2004","unstructured":"Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA . JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 2004; 18: 189\u2013218.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403370","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:42:01Z","timestamp":1648777321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,15]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6,1]]}},"alternative-id":["BF2403370"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403370","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,15]]},"assertion":[{"value":"10 July 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}